TNXP

TNXP, also known as Tenax Therapeutics, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies for critical care and other serious medical conditions. The company specializes in treatments that enhance oxygen delivery and support body function during critical illness. TNXP is involved in the development of drug candidates designed to improve patient outcomes in settings such as sepsis and other conditions where oxygen supply and demand are critically imbalanced.